The DOI matches its Crossref record; 56 of the 66 references it cites were found in a registry or an index.
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype
Open accessAbstract
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). The relentless spread and pathogenicity of the virus have become a global public health emergency. One of the striking features of this pandemic is the pronounced impact on specific regions and ethnic groups. In particular, compared with East Asia, where the virus first emerged, SARS-CoV-2 has caused high rates of morbidity and mortality in Europe. This has not been experienced in past global viral infections, such as influenza, severe acute respiratory syndrome (SARS) and Middle East respiratory syndrome (MERS) and is unique to SARS-CoV-2. For this reason, we investigated the involvement of genetic factors associated with SARS-CoV-2 infection with a focus on angiotensin-converting enzyme (ACE)-related genes, because ACE2 is a receptor for SARS-CoV-2. We found that the ACE1 II genotype frequency in a population was significantly negatively correlated with the number of SARS-CoV-2 cases. Similarly, the ACE1 II genotype was negatively correlated with the number of deaths due to SARS-CoV-2 infection. These data suggest that the ACE1 II genotype may influence the prevalence and clinical outcome of COVID-19 and serve as a predictive marker for COVID-19 risk and severity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the ACE1 II genotype is protective against COVID-19 as compared to the ACE1 DD genotype (358), and serum levels of ACE1 are higher in the DD genotype compared with the II genotype (359).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [358]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Saeed, M., Saleheen, D., Siddiqui, S., Khan, A., Butt, Z., & Frossard, P. (2005) · Hypertension Research · doi:10.1291/hypres.28.345 · Cited by 12
RetractedA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286 · cited 3×
“Moreover, because ACE2 is a receptor for SARS-COV-2 (Hoffmann et al., 2020), viral infection may lead to the suppression of ACE2 function and cause ACE1/ACE2 imbalance responsible for RAAS over-activation and pulmonary shutdown (Gemmati et al., 2020).”
BackgroundInfluentialRigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., & Soubrier, F. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114844 · Cited by 3,767
Sequence variation in the human angiotensin converting enzyme
Rieder, M. J., Taylor, S. L., Clark, A. G., & Nickerson, D. A. (1999) · Nature Genetics · doi:10.1038/8760 · Cited by 470
Marshall, R. P., Webb, S., Bellingan, G. J., Montgomery, H. E., Chaudhari, B., McAnulty, R. J., Humphries, S. E., Hill, M. R., & Laurent, G. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2108086 · Cited by 412
Gemmati, D., Bramanti, B., Serino, M. L., Secchiero, P., Zauli, G., & Tisato, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103474 · Cited by 409 · cited 2×
“Therefore, the balance between ACE1 and ACE2 is considered to be very important for maintaining homeostasis in the body (Chappel and Ferrario, 2006; Gemmati et al., 2020).”
BackgroundVariation in DCP1, encoding ACE, is associated with susceptibility to Alzheimer disease
Kehoe, P. G., Russ, C., McIlroy, S., Williams, H., Holmans, P., Holmes, C., Liolitsa, D., Vahidassr, D., Powell, J., McGleenon, B., et al. (1999) · Nature Genetics · doi:10.1038/5009 · Cited by 260
Iwai, N., Ohmichi, N., Nakamura, Y., & Kinoshita, M. (1994) · Circulation · doi:10.1161/01.cir.90.6.2622 · Cited by 245
Xiao, L., Sakagami, H., & Miwa, N. (2020) · Viruses · doi:10.3390/v12050491 · Cited by 193 · cited 1×
“Under physiological conditions, the signal from angiotensin (Ang) II generated by ACE1 is related to pathological conditions such as vasoconstriction, inflammation and fibrosis, and ACE2-derived peptide, Ang 1–7, reverses the action of Ang II via the Mas receptor (Xiao et al., 2020).”
Background
Research works printed but not linked: 4
- Borzyszkowska, 2012, Angiotensin converting enzyme gene polymorphism is associated with severity of coronary artery disease in men with high total cholesterol levels, J. Appl. Genet., 53, 175, 10.1007/s13353-012-0083-3 · DOI
- Gard, P.R. 2010. Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review. Int. J. Mol. Epidemiol.Genet., 1, 145-157 https://www.ijmeg.org/ijmeg102003.
- Gu, 1994, Lack of association between the I/D polymorphism of the angiotensin-converting enzyme gene and essential hypertension in a Belgian population, J. Hum. Hypertens., 8, 683
- Nikzamir, A., Nakhjavani, M., Golmohamadi, T., Dibai, L. 2008. Association of angiotensin-converting enzyme gene insetion/deletion polymorphism with metabolic syndrome in Iranians with type 2 diabetes Mellitus. Arch. Iranian Med., 11, 3-9 http://www.ams.ac.ir/AIM/NEWPUB/08/11/1/004.pdf. · DOI
Cited by
Sorted by citations
IL-6 in inflammation, autoimmunity and cancer
Hirano, T. (2021) · International Immunology · doi:10.1093/intimm/dxaa078 · Cited by 1,453
de Araújo, J. L. F., Menezes, D., Aguiar, R. S., & de Souza, R. P. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.775246 · Cited by 16
“Most previous findings report associations with COVID19 outcomes on a population level, indicating high variability on allelic frequencies across different populations (Delanghe et al., 2020; Pati et al., 2020; Yamamoto et al., 2020).”
Beyerstedt, S., Casaro, E. B., & Rangel, É. B. (2021) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-020-04138-6 · Cited by 897
“Therefore, the deletion allele is associated with COVID-19 progression [89] and SARS-CoV-2 infection rate and mortality [147], while the ACE1-II genotype negatively correlates with infection rate and mortality [149].”
BackgroundAngiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome
Gómez, J., Albaiceta, G. M., Clemente, M. M. G., López‐Larrea, C., Amado‐Rodríguez, L., López-Alonso, I., Hermida, T., Enríquez-Rodríguez, A. I., Herrero, P., Melón, S., et al. (2020) · Gene · doi:10.1016/j.gene.2020.145102 · Cited by 233
From delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants
PAPANIKOLAOU, V. S., Chrysovergis, A., Ragos, V., Tsiambas, E., Katsinis, S., Manoli, A., Papouliakos, S. M., Roukas, D., Mastronikolis, S. N., Peschos, D., et al. (2022) · Gene · doi:10.1016/j.gene.2021.146134 · Cited by 149
Terada, M., Ohtsu, H., Saito, S., Hayakawa, K., Tsuzuki, S., Asai, Y., Matsunaga, N., Kutsuna, S., Sugiura, W., & Ohmagari, N. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-047007 · Cited by 121
Halawa, S., Pullamsetti, S. S., Bangham, C. R. M., Stenmark, K. R., Dorfmüller, P., Frid, M. G., BUTROUS, G. S., Morrell, N. W., Pérez, V. D. J., Stuart, D. I., et al. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00640-2 · Cited by 84
Verma, S., Abbas, M., Verma, S., Khan, F. H., Raza, S. T., Siddiqi, Z., Ahmad, I., & Mahdi, F. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104801 · Cited by 90
“Similarly, other studies found that ACE1 D/D-genotype showed association with COVID-19 related mortality (Annunziata et al., 2020; Yamamoto et al., 2020).”
ResultSaengsiwaritt, W., Jittikoon, J., Chaikledkaew, U., & Udomsinprasert, W. (2022) · Reviews in Medical Virology · doi:10.1002/rmv.2323 · Cited by 71
“In terms of RAAS‐related genes, intron 16 of human ACE1 gene on chromosome 17 contains an Alu repeat insertion (I) or deletion (D).10 According to its variations, there are three distinctive genotypes: II, ID, and DD.11 A common I/D variant in ACE gene has been previously linked with several pathological conditions.12…”
BackgroundInfluentialYamamoto, N., & Bauer, G. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110160 · Cited by 69
“Very recently, we showed a strong negative correlation that the numbers of SARS-CoV-2 infected cases and deaths due to viral infection decreased with increasing ACE1 II genotype frequency [19].”
InfluentialSelf-citationGenetic Hypothesis and Pharmacogenetics Side of Renin-Angiotensin-System in COVID-19
Gemmati, D., & Tisato, V. (2020) · Genes · doi:10.3390/genes11091044 · Cited by 75
“recently reported detailed information on ACE1 I/I genotype rates among European, Middle Eastern, South Asian and East Asian countries, merging data from the Center for Systems Science and Engineering at Johns Hopkins University detailing ACE1 I/I genotype frequencies, number of affected cases/population and number of…”
BackgroundResultInfluentialGenetic and epigenetic factors associated with increased severity of Covid‐19
Yildirim, Z., Sahin, O. S., Yazar, S., & Çetintaş, V. B. (2021) · Cell Biology International · doi:10.1002/cbin.11572 · Cited by 72
Host gene variability and SARS-CoV-2 infection: A review article
Kaidashev, I., Shlykova, O., Izmailova, O., Torubara, O., Yushchenko, Y. O., Tyshkovska, T., Kyslyi, V., Belyaeva, A., & Maryniak, D. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e07863 · Cited by 60
“Similarly, the ACE1 II genotype is negatively correlated with the number of deaths from SARS-CoV-2 infection [76].”
Polymorphisms in ACE, ACE2, AGTR1 genes and severity of COVID-19 disease
Molina, M. S., Rocamora, E. N., Bendicho, A. I., Vázquez, E. G., Zorio, E., Rodriguez, F. D., Ortuño, C. G., Rodríguez, A. I., Sánchez-López, A., Rubio, R. J., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0263140 · Cited by 56
The Renin-Angiotensin System: A Key Role in SARS-CoV-2-Induced COVID-19
El-Arif, G., Farhat, A., Khazaal, S., Annweiler, C., Kovacic, H., Wu, Y., Cao, Z., Fajloun, Z., Khattar, Z. A., & Sabatier, J. (2021) · Molecules · doi:10.3390/molecules26226945 · Cited by 76
“Many studies described the association of the RAS component genetic variation with the prevalence of COVID-19 diseases [47,68].”
BackgroundInfluentialCafiero, C., Rosapepe, F., Palmirotta, R., Re, A., Ottaiano, M., Benincasa, G., Perone, R., Varriale, E., D’Amato, G., Cacciamani, A., et al. (2021) · Pharmacogenomics and Personalized Medicine · doi:10.2147/pgpm.s303666 · Cited by 53
“The results of this study, albeit with a limited but wellselected number of patients, suggest that some gene variants of RAAS pathway could modulate some pathological conditions associated with the heterogeneous clinical picture caused by SARS-CoV-2 infection such as disseminated intravascular coagulation and thrombos…”
ResultPrecision Medicine and Public Health: New Challenges for Effective and Sustainable Health
Traversi, D., Pulliero, A., Izzotti, A., Franchitti, E., Iacoviello, L., Gianfagna, F., Gialluisi, A., Izzi, B., Agodi, A., Barchitta, M., et al. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020135 · Cited by 74
“Another study investigated the involvement of genetic factors associated with SARS-CoV-2 infection, particularly ACE-related genes [164], showing a negative correlation with the number of cases and number of deaths due to viral infection, since both decreased with an increasing”
BackgroundDieter, C., Brondani, L. D. A., Leitão, C., Gerchman, F., Lemos, N. E., & Crispim, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0270627 · Cited by 48
“This Ins/Del variant results in alternative splicing, leading to protein shortening and loss of the catalytically active domain in ACE1 Ins allele carriers [92].”
BackgroundHuman gene polymorphisms and their possible impact on the clinical outcome of SARS-CoV-2 infection
Hashemi, S. M. A., Thijssen, M., Hosseini, S. Y., Tabarraei, A., Pourkarim, M. R., & Sarvari, J. (2021) · Archives of Virology · doi:10.1007/s00705-021-05070-6 · Cited by 56
Öz, M., & Lorke, D. E. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111193 · Cited by 57
Balzanelli, M. G., Distratis, P., Lazzaro, R., Pham, V. H., Tran, C. T., Dipalma, G., Bianco, A., Serlenga, E. M., Aityan, S. K., Pierangeli, V., et al. (2022) · Diagnostics · doi:10.3390/diagnostics12112824 · Cited by 43
Ishak, A., Mehendale, M., AlRawashdeh, M. M., Sestacovschi, C., Sharath, M., Pandav, K., & Marzban, S. (2022) · Gene · doi:10.1016/j.gene.2022.146674 · Cited by 44
Potential Genes Associated with COVID-19 and Comorbidity
Feng, S., Song, F.-Q., Guo, W., Tan, J., Zhang, X., Qiao, F., Guo, J., Zhang, L., & Jia, X. (2022) · International Journal of Medical Sciences · doi:10.7150/ijms.67815 · Cited by 44
“The frequency and mortality of COVID-19 patients are closely connected to the ACE-I/D genotype that may be detected for predicting the ponderance of COVID-19 [70].”
BackgroundCalabrese, C., Annunziata, A., Coppola, A., Pafundi, P., Guarino, S., Spirito, V. D., Maddaloni, V., Pepe, N., & Fiorentino, G. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2020.631148 · Cited by 41
Mir, R., Mir, R., Alghamdi, M. A. A., Alsayed, B. A., Wani, J. I., Alharthi, M. H., & Alshahrani, A. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11111098 · Cited by 45
“Role of RAAS in SARS-CoV-2 Infection Different ACE genotypes are believed to be associated with development of acute respiratory distress syndrome and several studies have reported that the distribution frequency of ACE insertion/insertion (II) genotype might have a significant influence on COVID-19 mortality [36,40].”
BackgroundAdli, A., Rahimi, M., Khodaie, R., Hashemzaei, N., & Hosseini, S. M. (2022) · Journal of Medical Virology · doi:10.1002/jmv.27615 · Cited by 46
ACE I/D polymorphism in Czech first-wave SARS-CoV-2-positive survivors
Hubáček, J., Dušek, L., Májek, O., Adámek, V., Červinková, T., Dlouhá, D., & Adámková, V. (2021) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2021.04.024 · Cited by 39
“Studies performed on Asian populations [24,28,29], reported opposite results and suggested a D/D genotype as a predictive marker of COVID-19 severity.”
Kouhpayeh, H. R., Tabasi, F., Dehvari, M., Naderi, M., Bahari, G., Khalili, T., Clark, C. J., Ghavami, S., & Taheri, M. (2021) · Translational Medicine Communications · doi:10.1186/s41231-021-00106-0 · Cited by 46
“also showed that the II genotype has a strong negative correlation with COVID-19 prevalence and death [59].”
BackgroundCCR5Delta32 deletion as a protective factor in Czech first-wave COVID-19 subjects.
Hubacek, J., Dušek, L., Májek, O., Adámek, V., Červinková, T., Dlouhá, D., Pavel, J., & Adámková, V. (2021) · Physiological Research · doi:10.33549/physiolres.934647 · Cited by 38
What could explain the late emergence of COVID-19 in Africa?
Lalaoui, R., Bakour, S., Raoult, D., Verger, P., Sokhna, C., Devaux, C. A., Pradines, B., & Rolain, J. (2020) · New Microbes and New Infections · doi:10.1016/j.nmni.2020.100760 · Cited by 38
Proline Isomerization: From the Chemistry and Biology to Therapeutic Opportunities
Gurung, D., Danielson, J. A., Tasnim, A., Zhang, J., Zou, Y., & Liu, J. (2023) · Biology · doi:10.3390/biology12071008 · Cited by 50
“Using cyclophilin inhibitors and RNA interference experiments, several groups have shown that CypA directly binds to HBX [212], and promotes HBV replication, production and secretion [213–215].”
BackgroundHuman genetic basis of coronavirus disease 2019
Deng, H., Yan, X., & Yuan, L. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00736-8 · Cited by 36
“Middle Eastern populations, particularly those in Lebanon with a relatively low I-allele frequency, are believed to be the ancestor of the ACE variant.(86) I/I genotype increases westwards and eastwards from the Middle East.”
BackgroundMouliou, D. S., Kotsiou, O. S., & Gourgoulianis, K. I. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18168701 · Cited by 37
“COVID-19 prevalence has negatively been correlated with ACE1 I allele frequency [31].”
BackgroundMilani, D., Caruso, L., Zauli, E., Owaifeer, A. M. A., Secchiero, P., Zauli, G., Gemmati, D., & Tisato, V. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.871583 · Cited by 37
“The main activity of these enzymes is significantly driven by common intragenic polymorphisms also characterized by a peculiar geographic distribution that disclosed exciting correspondences between haplotypes distribution and worldwide COVID-19 morbidity and mortality index (Yamamoto et al., 2020).”
BackgroundTakeshita, M., Nishina, N., Moriyama, S., Takahashi, Y., Uwamino, Y., Nagata, M., Aoki, W., Masaki, K., Ishii, M., Saya, H., et al. (2021) · Virology · doi:10.1016/j.virol.2020.12.020 · Cited by 31
“Several hypotheses, such as the difference in genetic backgrounds, socio-behavioral differences, mutations in SARS-CoV-2 genomes, and the possibility of having cross-reactive immunity to similar viruses, are inferred as causes of this difference but has not been identified (Yamamoto et al., 2020; Ng et al., 2020; Fors…”
Yamamoto, N., Nishida, N., Yamamoto, R., Gojobori, T., Shimotohno, K., Mizokami, M., & Ariumi, Y. (2021) · Genes · doi:10.3390/genes12101572 · Cited by 36
“Conversely, the number of cases and deaths in other regions, especially in largely populated East Asia, is much lower, and the racial differences are noteworthy [5].”
BackgroundSelf-citationBeauty and the beast: host microRNA-155 versus SARS-CoV-2
Papadopoulos, K., Papadopoulou, A., & Aw, T. (2023) · Human Cell · doi:10.1007/s13577-023-00867-w · Cited by 27
COVID-19 and syndemic challenges in ‘Battling the Big Three’: HIV, TB and malaria
Velavan, T., Meyer, C., Esen, M., Kremsner, P., & Ntoumi, F. (2021) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2021.03.071 · Cited by 27
Castelo-Branco, L., Tsourti, Z., Gennatas, S., Rogado, J., Sekacheva, M., Viñal, D., Lee, R., Croitoru, A., Vitorino, M., Khallaf, S., et al. (2022) · ESMO Open · doi:10.1016/j.esmoop.2022.100499 · Cited by 26
“Notably, a strong correlation was found between ACE1 II genotype, more frequent in Asians, and lower severity or death from COVID19.(39) All these factors may justify the favourable survival”
Yamamoto, N., Yamamoto, R., Ariumi, Y., Mizokami, M., Shimotohno, K., & Yoshikura, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22095000 · Cited by 31
“We recently reported significantly different infection and mortality rates for SARS-CoV-2 between European and East Asian populations, and this correlated with the ACE1 D/I genotype [7,8].”
Self-citationPabalan, N., Tharabenjasin, P., Suntornsaratoon, P., Jarjanazi, H., & Muanprasat, C. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104682 · Cited by 26
“The strong negative correlation between ACE II genotype frequency and the number of cases, as well as deaths from COVID-19 suggests a role for ACE II in the clinical outcome of COVID-19 and may be a predictive marker for COVID-19 risk (Yamamoto et al., 2020).”
Suh, S., Lee, S., Gym, H., Yoon, S., Park, S.-K., Cha, J., Kwon, D., Yang, Y.-S., & Sun, H.-J. (2022) · BMC Infectious Diseases · doi:10.1186/s12879-022-07034-w · Cited by 22
Íñiguez, M., Pérez‐Matute, P., Villoslada-Blanco, P., Recio‐Fernández, E., Ezquerro-Pérez, D., Machado‐Alba, J. E., Ferreira-Laso, M. L., & Oteo, J. A. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.688071 · Cited by 29
Cumpstey, A. F., Clark, A. D., Santolini, J., Jackson, A. A., & Feelisch, M. (2021) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0017 · Cited by 40
“The higher population frequency of this ACE insertion polymorphism also correlates strongly with both lower SARS-CoV-2 infection and COVID-19 mortality rate (467).”
Al-Eitan, L., & Alahmad, S. (2020) · Reviews in Medical Virology · doi:10.1002/rmv.2194 · Cited by 22
“to correlate with the variations in outcomes where populations with a high D genotype frequency tend to experience higher mortality rates.(39,40) Another study indicates that I/D polymorphism in the ACE1 gene is linked to the severity of the SARS‐CoV‐2 infection depending on the hypertensive condition of the patient.”
ResultSaad, H., Jabotian, K., Sakr, C. J., Mahfouz, R., Akl, I. B., & Zgheib, N. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.798571 · Cited by 21
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 27
Keikha, M., & Karbalaei, M. (2022) · Microbial Pathogenesis · doi:10.1016/j.micpath.2022.105781 · Cited by 23
“In this pathway, the angiotensinconverting enzyme (ACE or ACE1) converts angiotensin-1 (Ang-1) to Ang-2; on the other hand, ACE2 converts Ang-2 to Ang-(1-7) (6).”
InfluentialPapadopoulou, A., Fragkou, P., Maratou, E., Dimopoulou, D., Kominakis, A., Kokkinopoulou, I., Kroupis, C., Nikolaidou, A., Antonakos, G., Papaevangelou, V., et al. (2021) · Journal of Medical Virology · doi:10.1002/jmv.27417 · Cited by 18
“In the early pandemic, an extensive debate has been launched regarding the effect of the ACE I/D alleles on the prevalence and the outcome of the COVID‐19 infection.(7,8) First, Delanghe et al.”
BackgroundResultInfluentialA new framework for host-pathogen interaction research
Yu, H. J., Li, L., Huffman, A., Beverley, J. R., Hur, J., Merrell, E. C., Huang, H.-H., Wang, Y., Liu, Y., Ong, E., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1066733 · Cited by 19
“For example, hosts exhibiting the angiotensin converting enzyme 1 (ACE-1) II genotype, which is more prevalent in Western Europe and steadily decreases in frequency towards Eastern Asia, appears to negatively correlate with the manifestation of COVID-19, and thus related mortality rates (34).”
BackgroundFaridzadeh, A., Mahmoudi, M., Ghaffarpour, S., Zamani, M., Hoseinzadeh, A., Naghizadeh, M., & Ghazanfari, T. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.955965 · Cited by 17
“The prevalence and mortality rates of COVID-19 vary considerably from country to country, which raises the question of whether geographical origin and host genetic variations play a role in the severity and mortality of COVID19 infection.”
BackgroundInfluentialGenetics of COVID ‐19 and myalgic encephalomyelitis/chronic fatigue syndrome: a systematic review
Tziastoudi, M., Cholevas, C., Stefanidis, I., & Theoharides, T. C. (2022) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.51631 · Cited by 19
Association investigations between ACE1 and ACE2 polymorphisms and severity of COVID-19 disease
Najafi, M., & Mahdavi, M. (2022) · Zeitschrift für Induktive Abstammungs- und Vererbungslehre · doi:10.1007/s00438-022-01953-8 · Cited by 15
“1 3 on Asian populations (Pourbagheri-Sigaroodi et al. 2020; Yamamoto et al. 2020; Verma et al. 2021), reflecting the ethnicity-specific allelic effect.”
BackgroundJevnikar, K., Lapajne, L., Petrovič, D., Meglič, A., Logar, M., Valentinčič, N. V., Globočnik-Petrovič, M., Cileňsek, I., & Mekjavić, P. (2022) · Genes · doi:10.3390/genes13071111 · Cited by 15
“Individuals with a D/D genotype were shown to have a higher incidence of pulmonary embolism and increased mortality rates, possibly due to increased levels of serum ACE [19,27,28].”
BackgroundRestoring Trust: The Need for Precision Medicine in Infectious Diseases, Public Health and Vaccines
Equils, O., Bakaj, A., Wilson-Mifsud, B., & Chatterjee, A. (2023) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2023.2234787 · Cited by 15
Malinowska, J. K., & Żuradzki, T. (2022) · Medicine Health Care and Philosophy · doi:10.1007/s11019-022-10122-y · Cited by 25
Human genetic basis of severe or critical illness in COVID-19
Ji, X., Chen, B., Ze, B., & Zhou, W.-H. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.963239 · Cited by 14
“Another study also revealed a strong correlation between ACE1 insertion/deletion (I/D) genotype with COVID-19 mortalities (Yamamoto et al., 2020).”
BackgroundRepurposing of approved drugs with potential to interact with SARS-CoV-2 receptor
Ahsan, T., & Sajib, A. (2020) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2021.100982 · Cited by 13
Rezaiezadeh, J. S., Lord, J. S., Yekaninejad, M., & Izadi, P. (2022) · Human Gene · doi:10.1016/j.humgen.2022.201099 · Cited by 12
“Comparison of ACE1 genotypes frequencies data in different ethnicities with reported COVID-19 cases and mortality rate, showed that the frequency of ACE1 II genotype was negatively correlated with the number of SARS-CoV-2 infected cases and number of deaths due to SARS-CoV-2 infection (28).”
ResultHubáček, J. (2021) · Physiological Research · doi:10.33549/physiolres.934730 · Cited by 12
Age and genotype dependent erythropoietin protection in COVID-19
Papadopoulos, K. I., Sutheesophon, W., Manipalviratn, S., & Aw, T. C. (2021) · World Journal of Stem Cells · doi:10.4252/wjsc.v13.i10.1513 · Cited by 13
Oscanoa, T., Vidal, X., Coto, E., & Romero-Ortuño, R. (2021) · Arterial Hypertension · doi:10.5603/ah.a2021.0018 · Cited by 12
Boraey, N. F., Bebars, M. A., Wahba, A. A., El-Lateef, H. M. A., Attia, M., Elsayed, A. H., Rashed, K., Sorour, E., Ahmed, M. F., Abd-Elrehim, G. A. B., et al. (2024) · Pediatric Research · doi:10.1038/s41390-023-02982-8 · Cited by 11
“27,28 Verma et al. reported that carrying the ACE1 D/D genotype was associated with a 3.6-fold higher risk of severe COVID-19 in Indian population.”
InfluentialHost polymorphisms and COVID-19 infection
Delanghe, J., & Speeckaert, M. M. (2022) · Advances in clinical chemistry · doi:10.1016/bs.acc.2021.07.002 · Cited by 22
“correlated with susceptibility to SARS-CoV-2 infection and consequent mortality [56].”
BackgroundExploring AyuGenomics approach for understanding COVID-19 predisposition and progression
Bhat, V., Borse, S. P., Chavan-Gautam, P., & Joshi, K. (2021) · Journal of Ayurveda and Integrative Medicine · doi:10.1016/j.jaim.2021.06.003 · Cited by 11
“n between ACE1 II genotype and COVID-19 cases and deaths [55]”
Kusi, K. A., Frimpong, A., Partey, F. D., Lamptey, H., Amoah, L. E., & Ofori, M. F. (2021) · Open Research Africa · doi:10.12688/aasopenres.13196.3 · Cited by 11
“Indeed, Southern Asia has also recorded very few SARS-CoV-2 related severe disease and deaths 49 .”
Elbasan, O., Bayram, F., Yazan, C. D., Apaydın, T., Dashdamirova, S., Polat, H., Arslan, E., Yilmaz, I., Karimi, N., Sengel, B. E., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288338 · Cited by 10
“Although many studies have shown an association of the ACE DD genotype with the severity of COVID-19, others have indicated conflicting results [15, 17, 18, 25].”
BackgroundResultFiorentino, G., Benincasa, G., Coppola, A., Franzese, M., Annunziata, A., Affinito, O., Viglietti, M., & Napoli, C. (2022) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-022-02728-z · Cited by 9
Genetics and Molecular Biology
Cumming, A. M. (2021) · doi:10.1097/00041433-199206000-00014 · Cited by 9
Sacuena, E. R. P., Lima, C. N. C., Abreu, I., da Silva, L. M. C., Belleza, L. K. G., Lemes, R. B., de Araújo, G. S., da Silva, H. D., Vallinoto, A. C. D. R., & Guerreiro, J. (2024) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2024.105564 · Cited by 8
Aziz, M. A., & Islam, M. S. (2022) · Molecular Genetics & Genomic Medicine · doi:10.1002/mgg3.2063 · Cited by 8
“…during the postCOVID- 19 situation to correlate with the susceptibility of SARS- CoV- 2 infection, associated clinical outcomes, and mortality rate (Çelik et al., 2021; Delanghe et al., 2020; Gómez et al., 2020; Hatami et al., 2020; Pati et al., 2020; Saadat, 2020; Yamamoto et al., 2020).”
BackgroundHuman interaction targets of SARS-CoV-2 spike protein: A systematic review
Faraji, S. N., Raee, M. J., Hashemi, S. M. A., Daryabor, G., Tabrizi, R., Dashti, F. S., Behboudi, E., Heidarnejad, K., Nowrouzi‐Sohrabi, P., & Hatam, G. (2022) · European Journal of Inflammation · doi:10.1177/1721727x221095382 · Cited by 16
Could the CCR5-Δ32 Mutation be Protective in SARS-CoV-2 Infection?
Čizmarević, N. S., Kapović, M., Rončević, D., & Ristić, S. (2021) · Physiological Research · doi:10.33549/physiolres.934725 · Cited by 8
Livshits, L., Harashchenko, T., Umanets, T., Krasnienkov, D. S., Gorodna, O., Podolskiy, V., Kaminska, T., Lapshyn, V., Podolskiy, V., & Antipkin, Y. (2021) · Cytology and Genetics · doi:10.3103/s0095452721050054 · Cited by 8
Illi, B., Vasapollo, B., Valensise, H. C. C., & Totta, P. (2021) · Reproductive Medicine · doi:10.3390/reprodmed2020010 · Cited by 9
“Intriguingly, the II ACE genotype is inversely correlated both to COVID-19 incidence and mortality [95], suggesting the DD genotype as a predisposing factor to develop the disease and confirming hypertension as an underlying clinical condition contributing to the pathogenesis of both COVID-19 and PE.”
MethodOyeleye, S. I., Ojo, O. R., Ajeigbe, A. S., & Oboh, G. (2024) · Comparative Clinical Pathology · doi:10.1007/s00580-024-03611-4 · Cited by 5
“It works by converting angiotensin I into angiotensin II, a potent vasoconstrictor, which helps to increase blood pressure (Yamamoto et al. 2020).”
de Sousa, R. B. N., Nascimento, L. D. D., Costa, L. H. A., Leite, V. R. M. C., Borges, C. L., de Deus, J. M., Rebelo, A., Pinheiro, D. D. S., & Pedrino, G. (2023) · PLoS ONE · doi:10.1371/journal.pone.0288178 · Cited by 7
“Then, an ecological study conducted by Yamamoto et al. (2020) [52] involving data from 26 countries in Europe and Asia reported a negative ACE II genotype correlation with the number of COVID-19 cases (R = − 0.847) and deaths (R = − 0.755).”
BackgroundInfluentialTong, J., Chen, Y., He, M., Wang, W., Wang, Y., Li, N., & Xia, Q. (2023) · Frontiers in Microbiology · doi:10.3389/fmicb.2023.1190939 · Cited by 9
“Moreover, some researchers hypothesized that regional differences in allele frequencies might explain different incidence and mortality rates (Cao et al., 2020; Yamamoto et al., 2020).”
BackgroundRani, S., & Jain, A. (2023) · Multimedia Tools and Applications · doi:10.1007/s11042-023-15539-y · Cited by 10
“Another study was done by Yamamoto N et al. (2020) [109] for investigating the involvement of genetic factors linked with SARS-CoV-2 infection.”
Cenanovic, M., Dogan, S., Ašić, A., Bešić, L., & Marjanović, D. (2021) · Genetic Testing and Molecular Biomarkers · doi:10.1089/gtmb.2020.0207 · Cited by 7
Papadopoulos, K., Papadopoulou, A., & Aw, T. (2022) · Human Cell · doi:10.1007/s13577-022-00819-w · Cited by 6
“SNPs involving all the above-mentioned RAAS molecules, (ACE/ACE2/AGT/AGTR1), while protective in malaria, have been implicated in severe adult COVID-19 outcomes (Table 2) [104, 106, 115].”
BackgroundEffects of Human Genetic Factors (Ethnicity and Race) on Clinical Severity of SARS-CoV-2 (COVID-19)
Gökçe, I., Aydemir, K., Ayan, S., Altuntaş, İ., & Erbaş, O. (2021) · Journal of Experimental and Basic Medical Sciences · doi:10.5606/jebms.2020.75631 · Cited by 6
“[17] ACE1 II polymorphism has been found to be associated with lower death and infection rate of SARS-CoV-2 infection.[17] It is determined the European population has a lower frequency of ACE1 II genotype, and this situation might explain higher mortality and prevalence rates of COVID-19 infection in the European reg…”
BackgroundInfluentialAbbaszadeh, H., Kabiri-rad, H., Mohammadi, F., Zangoie, S., Rajabi-Moghaddam, M., Ghafari, S., Ziaee, M., Javanmard, D., & Miri-Moghaddam, E. (2024) · Biochemical Genetics · doi:10.1007/s10528-024-10722-8 · Cited by 5
“Studies performed on Asians showed that the patients with the low DD genotype and a higher II genotype frequency have a statistically significant lower mortality (Pati et al. 2020; Yamamoto et al. 2020; Verma et al. 2021 ).”
Khullar, N., Bhatti, J. S., Singh, S., Thukral, B., Reddy, P. H., & Bhatti, G. K. (2023) · World Journal of Gastroenterology · doi:10.3748/wjg.v29.i14.2064 · Cited by 5
Li, L., & Murakami, S. (2022) · medRxiv · doi:10.3390/ijms24043411 · Cited by 5
“In addition, the D-allele has been linked with higher mortality rates from COVID-19 [19].”
BackgroundResultBaştuğ, S., Cavdarli, B., Baştuğ, A., Sencan, I., Tuncez, E., Çakir, E., Kemirtlek, N., Sakar, C., Erdem, D., Ceylan, G., et al. (2021) · Anatolian journal of cardiology · doi:10.5152/anatoljcardiol.2021.502 · Cited by 5
“(1) reported that the prevalence of ACE1 II genotype in the population was negatively correlated with the mortality because of COVID-19.”
BackgroundSaid, R., Jenni, R., Boussetta, S., Ammous, F., Zouari, S., Zaghbib, S., Chakroun, M., Derouiche, A., Chebil, M., & Ouerhani, S. (2021) · Journal of clinical laboratory analysis (Print) · doi:10.1002/jcla.24129 · Cited by 5
Singh, H., Nair, A., & Mahajan, S. (2024) · Pathology, Research and Practice · doi:10.1016/j.prp.2024.155608 · Cited by 4
Sahranavard-Pirbazari, P., Khoshghiafeh, A., Kamali, M., Esfandiar, H., Bakhtiari, M., & Ahmadifard, M. (2023) · Advances in Medical Sciences · doi:10.1016/j.advms.2023.10.010 · Cited by 4
Genetic Variants and Protective Immunity against SARS-CoV-2
Rabaan, A., Mutair, A. A., Aljeldah, M., Shammari, B. A. A., Sulaiman, T., Alshukairi, A., Alfaresi, M., Al-Jishi, J. M., Bati, N. A. A., Al-Mozaini, M. A., et al. (2022) · Genes · doi:10.3390/genes13122355 · Cited by 4
“In European and Asian nations, however, greater frequency of the I/I genotype was negatively associated with vulnerability to SARS-CoV-2 infection and subsequent death [73].”
BackgroundInfluentialRezaei, M., Mohammadpour, H., Eftekhari, M., Pourabdollah, M., Azadani, F. N., Tabarsi, P., Marjani, M., & Ziai, S. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.1035796 · Cited by 4
Takeyama, M., Yachi, S., Nishimoto, Y., Tsujino, I., Nakamura, J., Yamamoto, N., Nakata, H., Ikeda, S., Umetsu, M., Aikawa, S., et al. (2022) · Journal of Epidemiology · doi:10.2188/jea.je20220201 · Cited by 4
Self-citationGoren, T., Yılmaz, A., Uluturk, M., Sabırlı, R., Kemancı, A., Seyit, M., Ozen, M., Oskay, A., Koseler, A., & Turkcuer, I. (2022) · Cureus · doi:10.7759/cureus.31201 · Cited by 4
“Some evidence implicates the association between ACE D/D genotype and increased mortality risk for SARS-CoV-2 [24].”
BackgroundYoshihara, F., Ohtsu, H., Nakai, M., Tsuzuki, S., Hayakawa, K., Terada, M., Matsunaga, N., Yasuda, S., Ogawa, H., & Ohmagari, N. (2022) · Journal of Cardiology · doi:10.1016/j.jjcc.2022.04.001 · Cited by 4
“ACE1 II genotype frequency is higher in Asians, including Japanese, than in Europeans and Middle Eastern individuals, and the ACE1 II genotype has been associated with a lower risk of COVID-19 aggravation [30].”
The Impact of COVID-19 on Gastrointestinal Motility Testing in Asia and Europe
Mori, H., Schol, J., Geeraerts, A., Huang, I., Jandee, S., Gonlachanvit, S., Tseng, P.-H., Lu, C.-L., Kamiya, T., Kim, N., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103189 · Cited by 4
“Although the reason is not yet fully elucidated, the infection and mortality rates of COVID-19 differ significantly between Asia and Europe [10] (Supplementary Table S1).”
BackgroundInfluentialPrognostic Value of CYP1A2 (rs2069514 and rs762551) Polymorphisms in COVID-19 Patients
Bozkurt, I., Gozler, T., Yüksel, İ., Ulucan, K., & Tarhan, K. N. (2023) · Balkan Journal of Medical Genetics · doi:10.2478/bjmg-2023-0005 · Cited by 3
“Yamamoto et al. (2020) showed that the ACE II genotype was negatively associated with the number of SARS-CoV-2 cases and deaths in East Asia [26].”
Backgroundla Cruz-Cano, E. D., Jiménez-González, C. D. C., Díaz-Gandarilla, J. A., López-Victorio, C. J., Escobar-Ramírez, A., Uribe-López, S. A., Huerta-Garcia, E., Ayala-Sumuano, J., Morales-García, V., Gútierrez-López, L., et al. (2022) · F1000Research · doi:10.12688/f1000research.74023.2 · Cited by 3
Acute Ischemic Stroke Due to Basilar Artery Occlusion with Coronavirus Disease 2019: A Case Report
Tsuchiya, T., Koizumi, S., Tomioka, A., Miyawaki, S., & Saito, N. (2021) · NMC Case Report Journal · doi:10.2176/nmccrj.cr.2021-0043 · Cited by 3
Influência da suscetibilidade genética na incidência e mortalidade de COVID-19 (SARS-CoV-2)
Galisa, S. L. G., Almeida, R. M. D. S., Soares, A. R. A. P., Ribeiro, R. R. A., Pereira, F. R. A., Gomes, K. A. L., de Oliveira, M. E. C., Nóbrega, W. F. S., Andrade, L. S. D. S., Santos, T. T. D. M., et al. (2021) · Research Society and Development · doi:10.33448/rsd-v10i1.11812 · Cited by 4
Mahmood, A. H., Al-Awadi, S. J. A., Al-Attar, M. M., Alshammary, R. A. A., & Abbood, R. S. (2024) · Human Gene · doi:10.1016/j.humgen.2024.201344 · Cited by 7
Metadata
- Authors
- Yamamoto, N., Ariumi, Y., Nishida, N., Yamamoto, R., Bauer, G., Gojobori, T., Shimotohno, K., & Mizokami, M.
- Affiliations
- National Center for Global Health and Medicine (JP)
- Joint Research Center for Human Retrovirus Infection, Kumamoto University (JP)
- Keio University (JP)
- University of Freiburg (DE)
- King Abdullah University of Science and Technology (SA)
- Corresponding author
- Yamamoto, Naoki
- Shimotohno, Kunitada
- Mizokami, Masashi
- ORCID
- Venue
- Gene
- Publisher
- Elsevier BV
- Published
- 2020-10
- Volume
- 758
- Pages
- 144944
- ISSN
- 0378-1119 (ISSN-L)
- PMC
- PMC7833925
- OpenAlex
- W3038462367
- Cited by
- 141
- References
- 66
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 15 · 2023: 20 · 2022: 36 · 2021: 54 · 2020: 11
- FWCI
- 3.97
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gene (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- King Abdullah University of Science and Technology Repository (King Abdullah University of Science and Technology) (submittedVersion, cc-by-nc-nd)
- Funders
- Japan Society for the Promotion of Science (18K08438)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, ACE2 receptor, genetic susceptibility, COVID-19 mortality
- MeSH terms
- Betacoronavirus, Angiotensin-Converting Enzyme 2, COVID-19, SARS-CoV-2, Asia, Europe, Gene Frequency, Genotype, Humans, Peptidyl-Dipeptidase A, Pneumonia, Viral, Risk, Risk Factors, Severity of Illness Index, Treatment Outcome, Coronavirus Infections, Polymorphism, Single Nucleotide, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
